Arnab Basu

Title: Innovations and Contributions of Inventor Arnab Basu

Introduction

Arnab Basu is a notable inventor based in Acton, MA (US), recognized for his significant contributions to the field of virology. With a total of five patents to his name, he has made strides in developing therapeutics aimed at combating viral infections, particularly those caused by filoviruses.

Latest Patents

One of his latest patents is focused on broad-spectrum inhibitors of filoviruses. This invention pertains to the development of therapeutics and prophylactics for the treatment and prevention of filovirus infections in humans and other mammals. The patent discloses a new class of small molecules that inhibit the interaction of naturally processed filovirus glycoprotein with its host receptor, Niemann-Pick C1 protein. This innovation aims to block the infection of host cells by filoviruses. Another significant patent involves inhibitors of viral entry into mammalian cells. This invention relates to compounds and methods for inhibiting viral infections in mammals. A pseudotype virus was developed for use in a high-throughput assay to identify nonpeptidic small molecule inhibitors that prevent viral entry into host cells.

Career Highlights

Throughout his career, Arnab Basu has worked with various organizations, including Microbiotix, Inc. and Saint Louis University. His work has been instrumental in advancing the understanding and treatment of viral infections.

Collaborations

Arnab has collaborated with notable colleagues, including Debra M Mills and John D Williams, contributing to a rich exchange of ideas and innovations in his field.

Conclusion

Arnab Basu's innovative work in developing antiviral therapeutics showcases his commitment to addressing critical health challenges. His contributions continue to impact the field of virology and inspire future research endeavors.